đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to conduct long-term surveillance for efficacy...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-18
Trial ID
NCT02207816
GSK Biologicals is developing in partnership with the Malaria Vaccine Initi...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-03-15
Trial ID
NCT00197067
Treatments Being Tested
The purpose of this observer-blind study is to gather key efficacy, safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-27
Trial ID
NCT00866619
This study will evaluate whether administration of two investigational mala...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-08-10
Trial ID
NCT01366534
This study is being done to assess the possibility of the potential integra...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-30
Trial ID
NCT00436007
Treatments Being Tested
GSK Biologicals is developing a number of candidate malaria vaccines for th...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-07
Trial ID
NCT00307021
Treatments Being Tested
This phase IIb trial is being done to find out if the RTS,S/AS01 vaccine he...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-01-03
Trial ID
NCT00380393
Treatments Being Tested
This study has been designed to support the indication of the candidate vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-17
Trial ID
NCT01345240
This study is designed to evaluate safety, reactogenicity, immunogenicity, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-20
Trial ID
NCT01857869
Treatments Being Tested
The aim of the malaria vaccine program of the MVI/GSK partnership is to dev...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-13
Trial ID
NCT01231503